-
PBS Liposomes for Macrophage Depletion Controls
2026-09-05
PBS Liposomes provide a phagocytosis-matched, non-depleting comparator for separating clodronate cargo effects from liposome delivery effects. This guide translates that control logic into reproducible in vivo workflows, uptake assays, troubleshooting steps, and mechanism-aware study design.
-
2-NBDG: From Uptake Signal to Mechanism
2026-09-04
2-NBDG can do more than quantify cellular glucose entry. This mechanistic guide shows how to interpret transporter uptake, hexokinase-dependent retention, and assay artifacts when studying glucose metabolism, toxicology, cancer, and diabetes research.
-
Chlorambucil: Reading Cell-Killing Data Correctly
2026-09-04
Chlorambucil is a nitrogen mustard alkylating agent whose apparent potency can change with the assay endpoint. This guide applies a dissertation-derived framework to distinguish growth inhibition from true cell death and improve interpretation across cancer models.
-
A23187, Free Acid: From Calcium Flux to Translation
2026-09-03
A mechanistic and translational framework for using A23187, free acid as a calcium ionophore in cell-based research. The article connects intracellular Ca2+ elevation with phosphoinositide signaling, ROS generation, mitochondrial permeability transition, and context-dependent cell death while showing why calcium flux should not be treated as a surrogate for apoptosis. It also provides workflow guidance, product-handling considerations, and a strategy for positioning A23187 as a benchmark perturbation in in vitro drug-response studies.
-
Oleanolic Acid, FXR, and Cholestatic Liver Injury
2026-09-03
The reference study identifies a linked mechanism in which oleanolic acid impairs hepatocyte tight junctions and disrupts FXR-regulated bile acid efflux through BSEP and MRP2. By combining in vivo and in vitro injury models with LC-MS/MS, immunofluorescence, and pharmacological intervention, it connects transporter dysfunction to cholestatic liver damage and provides a framework for testing FXR-centered mechanisms.
-
Ganoderma Polysaccharide Improves mRNA-LNP Efficacy
2026-09-02
The 2026 reference study identifies Ganoderma lucidum polysaccharide (GLP) as a potential adjuvant for mRNA lipid nanoparticles, linking improved protein expression to reduced oxidative stress and Nrf2-associated redox regulation. Its screening-to-validation workflow provides a practical framework for evaluating natural polysaccharides as functional components of mRNA delivery systems, while also defining important limits on transfer to other reporter platforms.
-
Ciprofloxacin Hydrochloride Assay Workflow
2026-09-02
This scenario-based guide explains how Ciprofloxacin (hydrochloride), SKU C5539, can support controlled antibacterial, combination, and cell-based assay workflows. It connects mechanism, solution preparation, cross-domain interpretation, and vendor selection to practical laboratory decisions.
-
Lipid Peroxidation (MDA) Assay Kit Guide
2026-09-01
Quantify malondialdehyde across tissues, cells, and biofluids with a dual-readout workflow built for oxidative stress and ferroptosis research. This guide shows how to pair MDA measurements with orthogonal endpoints, control matrix effects, and translate findings from doxorubicin-induced liver injury studies into reproducible experiments.
-
A40926: From Fermentation to Assay Insight
2026-09-01
A40926 is a dalbavancin precursor whose biosynthetic engineering offers practical lessons for assay design. This evidence-based guide connects strain optimization, cell-wall pharmacology, MIC interpretation, and translational antibacterial research.
-
Qushi Huoxue Ointment in MASLD: Mechanistic Study
2026-08-31
A 2026 World Journal of Hepatology study reports that Qushi Huoxue ointment reduced steatosis and inflammatory injury in a mouse model of metabolic associated steatotic liver disease by coordinating autophagy activation with ferroptosis suppression. Its integrated use of serum LC-MS/MS, network pharmacology, molecular validation, and electron microscopy provides a useful mechanistic framework, although causal and clinical validation remain necessary.
-
D-N-Acetylgalactosamine: Practical Lab Guide
2026-08-31
D-N-Acetylgalactosamine provides a defined, water- or DMSO-soluble reagent for glycoprotein and glycosylation studies, including brain heteropolysaccharides analysis. It should not be selected for ethanol-based workflows or long-term storage of prepared solutions, and application-specific validation is required because no directly matched paper evidence is supplied here.
-
WEHI-539: A Selective BCL-XL Inhibitor Workflow
2026-08-30
WEHI-539 provides a mechanistically focused way to test whether cell survival depends on BCL-XL rather than applying a nonspecific cytotoxic challenge. This guide connects apoptosis assays, MCL-1 interaction studies, glioblastoma models, and cancer stem cell sensitization with practical workflow and troubleshooting advice.
-
Cisplatin Beyond Cytotoxicity: A Renal Toxicity Lens
2026-08-29
Cisplatin is more than a DNA-damaging anticancer tool: its renal effects can reveal how acute injury progresses toward inflammation and fibrosis. This guide integrates CDDP chemistry, assay design, and SMYD2-based mechanistic insights for more informative cancer research.
-
PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress
2026-08-28
The reference study links perfluorooctane sulfonate exposure to human kidney tubular-cell injury through coordinated ferroptosis and endoplasmic reticulum stress responses. Its integrated biomarker strategy provides a mechanistic framework for studying PFOS nephrotoxicity and evaluating pathway-directed interventions.
-
Lanabecestat (AZD3293) in BACE1 Research
2026-08-28
Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition in neuronal models, helping researchers connect amyloid-beta production inhibition with functional synaptic measurements. This workflow-focused guide shows how to model partial inhibition, preserve assay interpretability, and troubleshoot discordant amyloid and electrophysiology results.